SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : A crash for the markets - a crash for biotechs ?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: trevor john wilkinson who wrote (18)12/11/1996 8:04:00 AM
From: Harold Engstrom   of 74
 
I think the longer interest rates stay low and the longer earnings continue to climb, the higher a premium people seem to be willing to pay for stock. Many sectors are not the bargain I would look for, but biotech seems to be a decent market now. I own Biogen, Genzyme, Genetics Institute and Immulogic. Genzyme in particular seems even undervalued: selling at only twice book value, with consistent and guaranteed earnings that would seem to put a floor PE of 20 under them, and a strong potential pipeline. Not all biotechs are that strong, but there are many with great stories and huge potential. If the market fundementals like earnings and inflation turn, then everything is overvalued, but if not then prices are not too far out of whack. All the best,

Harold Engstrom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext